Millennium Management
INO icon

Millennium Management’s Inovio Pharmaceuticals INO Stock Holding History

Millennium Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-833
Closed -$116 – 5383
2020
Q3 		$116 Buy
+833
New +$174K ﹤0.01% 4200
2014
Q3 		– Sell
-54,225
Closed -$7.04M – 3833
2014
Q2 		$7.04M Buy
+54,225
New +$6.4M 0.02% 1005

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management's INO Position: Q1 2026 in Review

Millennium Management increased its Inovio Pharmaceuticals (INO) stake by 0.53% in Q1 2026, buying an estimated $12.3K and bringing the position to 1,410,845 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3674.

Millennium Management first reported a position in INO in Q1 2014 and has held it in 37 quarters since. The position peaked at $12.6M in Q1 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

  • Millennium Management held 1,410,845 shares of Inovio Pharmaceuticals worth $2.45M as of Q1 2026.
  • Millennium Management bought 7,466 Inovio Pharmaceuticals shares in Q1 2026, an estimated $12.3K.
  • Inovio Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3674 holding.
  • Millennium Management first reported a position in Inovio Pharmaceuticals in Q1 2014 and has held it in 37 quarters since.
  • Millennium Management's Inovio Pharmaceuticals position peaked at $12.6M in Q1 2020.
  • 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.